A Post-Hoc Analysis of the Effect of Smoking Status on COPD Exacerbation Reductions with Budesonide/Glycopyrrolate/Formoterol Fumarate in Patients with COPD in the ETHOS Study

被引：0
作者：
Bafadhel, M. [1 ]
Han, M. K. [2 ]
Singh, D. [3 ]
Jenkins, M. [4 ]
Dorinsky, P. [5 ]
Patel, M. [4 ]
机构：
[1] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England
[2] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[3] Univ Manchester, Manchester Univ NHS Fdn Trust, Med Evaluat Unit, Manchester, Lancs, England
[4] AstraZeneca, Cambridge, England
[5] AstraZeneca, Durham, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1451
引用
收藏
页数：2
相关论文
共 50 条
[21]   Cardiopulmonary Risk Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Triple Therapy: A Number Needed to Treat Post Hoc Analysis of the ETHOS Trial [J].
Singh, D. ;
Marshall, J. ;
Martinez, F. J. ;
Hurst, J. R. ;
Han, M. K. ;
Gale, C. P. ;
Fredriksson, M. ;
Kisielewicz, D. ;
Mushunje, A. ;
Movitz, C. ;
Ojili, N. ;
Parikh, H. ;
Arya, N. ;
Bowen, K. ;
Patel, M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2025, 211
[22]   Budesonide/Glycopyrrolate/Formoterol Fumarate Effects on Exacerbations of Chronic Obstructive Pulmonary Disease Based on Airflow Limitation: A Post-hoc Analysis of the KRONOS Study [J].
Martinez, F. J. ;
Wang, C. ;
Stolz, D. ;
Marshall, J. ;
Bowen, K. ;
Patel, M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[23]   Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS [J].
Chen Wang ;
Ting Yang ;
Jian Kang ;
Rongchang Chen ;
Li Zhao ;
Huijie He ;
Pryseley N. Assam ;
Rong Su ;
Eric Bourne ;
Shaila Ballal ;
Kiernan DeAngelis ;
Paul Dorinsky .
Advances in Therapy, 2020, 37 :1591-1607
[24]   Triple Therapy with Budesonide/Glycopyrronium/ Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS [J].
Muro, Shigeo ;
Seki, Munehiro ;
Hurst, John R. ;
Petullo, David ;
Marshall, Jonathan ;
Bowen, Karin ;
Darken, Patrick F. ;
Duncan, Elizabeth A. ;
Megally, Ayman ;
Patel, Mehul .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 :2729-2737
[25]   Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS [J].
Bafadhel, Mona ;
Rabe, Klaus F. ;
Martinez, Fernando J. ;
Singh, Dave ;
Darken, Patrick ;
Jenkins, Martin ;
Aurivillius, Magnus ;
Patel, Mehul ;
Dorinsky, Paul .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 :3061-3073
[26]   Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial [J].
Rabe, Klaus F. ;
Martinez, Fernando J. ;
Singh, Dave ;
Trivedi, Roopa ;
Jenkins, Martin ;
Darken, Patrick ;
Aurivillius, Magnus ;
Dorinsky, Paul .
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2021, 15
[27]   Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS [J].
Wang, Chen ;
Yang, Ting ;
Kang, Jian ;
Chen, Rongchang ;
Zhao, Li ;
He, Huijie ;
Assam, Pryseley N. ;
Su, Rong ;
Bourne, Eric ;
Ballal, Shaila ;
DeAngelis, Kiernan ;
Dorinsky, Paul .
ADVANCES IN THERAPY, 2020, 37 (04) :1591-1607
[28]   Prompt Initiation of Budesonide/Glycopyrrolate/Formoterol Fumarate (BGF) After an Exacerbation Is Associated With Reduced Exacerbation and Cardiopulmonary Risk in Patients With COPD: The MITOS EROS plus CP (US) Study [J].
Pollack, M. ;
Tkacz, J. ;
Schinkel, J. ;
Agatep, B. ;
Portillo, E. ;
Germack, H. D. ;
Crooks, M. G. ;
Strange, C. ;
Marshall, J. ;
Muellerova, H. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2025, 211
[29]   The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [J].
Calverley, Peter M. A. ;
Papi, Alberto ;
Page, Clive ;
Rogliani, Paola ;
Negro, Roberto W. Dal ;
Cazzola, Mario ;
Cicero, Arrigo F. ;
Wedzicha, Jadwiga A. .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 :1909-1920
[30]   Improvements in Lung Function with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Patients with COPD: A Sub-Study of the ETHOS Trial [J].
Rabe, K. F. ;
Martinez, F. J. ;
Singh, D. ;
McLaren, J. ;
St Rose, E. ;
Ballal, S. ;
Darken, P. ;
Aurivillius, M. ;
Reisner, C. ;
Dorinsky, P. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345